Arshed Quyyumi
Emory University · Emory Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Arshed Quyyumi as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:16 UTC. Open this list on ClinicalTrials.gov
- N/ANCT05256706 · SomaSignal Tests on Medical Management and Change in Risk in Patients With DiabetesEmory University · completed · Diabetes Mellitus, Type 2 · principal investigator
- N/ANCT04755413 · The Precision CAD TrialEmory University · active not recruiting · Coronary Artery Disease · principal investigator
- N/ANCT03308812 · The Morehouse-Emory Cardiovascular Center for Health Equity Study: Clinical Intervention ProjectEmory University · completed · Cardiovascular Diseases · principal investigator
- Ph2NCT03304821 · Granulocyte-Macrophage Stimulating Factor (GM-CSF) in Peripheral Arterial DiseaseEmory University · completed · Peripheral Artery Disease (PAD) · principal investigator
- N/ANCT02657382 · Mental Stress Ischemia: Biofeedback StudyEmory University · completed · Cardiovascular Disease, Coronary Artery Disease · principal investigator
- Ph4NCT02566577 · Physiologic Effects of RBC TransfusionEmory University · terminated · Red Blood Cell Transfusion · principal investigator
- Ph2NCT01495364 · NBS10 (Also Known as AMR-001) Versus Placebo Post ST Segment Elevation Myocardial InfarctionLisata Therapeutics, Inc. · completed · ST Segment Elevation Myocardial Infarction · principal investigator
- Ph2NCT01041417 · Granulocyte-Macrophage Stimulating Factor in the Treatment of Peripheral Arterial DiseaseEmory University · completed · Peripheral Arterial Disease · principal investigator
- Ph4NCT01041287 · Effect of Nebivolol on Oxidative Stress and Endothelial Progenitor CellsEmory University · completed · Hypertension · principal investigator
- N/ANCT00384761 · Predictive Medicine ResearchEmory University · completed · Atherosclerosis, Endothelial Dysfunction · principal investigator
- N/ANCT00336869 · Partnership Programs to Reduce Cardiovascular Disparities- Morehouse- Emory PartnershipEmory University · completed · Metabolic Syndrome · principal investigator
- Ph2NCT00208767 · Effect of Valsartan on Carotid Artery DiseaseEmory University · completed · Carotid Artery Diseases, Atherosclerosis · principal investigator
- N/ANCT00211081 · Spironolactone in Patients With Single Ventricle HeartEmory University · completed · Congenital Disorders · principal investigator
- N/ANCT00101517 · Partnership Programs to Reduce Ethnic Differences in the Risk of Cardiovascular DiseaseEmory University · completed · Cardiovascular Diseases, Heart Diseases, Obesity · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:16 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 9 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Precision Cardiovascular Diseases Phenotyping and Pathophysiological Pathways in the CARRS Cohort (Precision-CARRS)P01HL154996 · NHLBI · EMORY UNIVERSITY · fiscal years 2022 to 2026 · $426,183 awarded in 2026Same name and institution; not confirmed by an ID
- Cardiovascular Project 3U54AG062334 · NIA · EMORY UNIVERSITY · fiscal years 2018 to 2022 · $323,634 awarded in 2022Same name and institution; not confirmed by an ID
- Granulocyte-Macrophage Colony Stimulated Factor (GM-CSF) in Peripheral Arterial DiseaseR33HL138657 · NHLBI · EMORY UNIVERSITY · fiscal years 2018 to 2021 · $740,646 awarded in 2021Same name and institution; not confirmed by an ID
- Core to Support Underserved or Health Disparity PopulationsP30DK111024 · NIDDK · EMORY UNIVERSITY · fiscal years 2016 to 2020 · $107,488 awarded in 2020Same name and institution; not confirmed by an ID
- Granulocyte-Macrophage Colony Stimulated Factor (GM-CSF) in Peripheral Arterial DiseaseR61HL138657 · NHLBI · EMORY UNIVERSITY · fiscal years 2017 · $775,100 awarded in 2017Grant number is on one of their registry trials
- The role of the renin-angiotensin-endothelial pathway in ADRF1AG051633 · NIA · EMORY UNIVERSITY · fiscal years 2015 to 2017 · $298,038 awarded in 2017Same name and institution; not confirmed by an ID
- Mental Stress Ischemia: Prognosis and Genetic InfluencesP01HL101398 · NHLBI · EMORY UNIVERSITY · fiscal years 2010 to 2015 · $2,125,629 awarded in 2015Same name and institution; not confirmed by an ID
- Injury and Repair Factors Promoting Atherosclerosis in HIVR56HL126558 · NHLBI · EMORY UNIVERSITY · fiscal years 2014 · $758,413 awarded in 2014Same name and institution; not confirmed by an ID
- Phase II study: Mobilization of progenitor cells in peripheral arterial diseaseRC2HL101515 · NHLBI · EMORY UNIVERSITY · fiscal years 2009 to 2010 · $1,193,039 awarded in 2010Grant number is on one of their registry trials
- Endothelial Hyperpolarization in HumansR01HL079115 · NHLBI · EMORY UNIVERSITY · fiscal years 2005 to 2008 · $362,679 awarded in 2008Same name and institution; not confirmed by an ID
- The Emory-Morehouse Partnership to Reduce CV DisparitiesU01HL079156 · NHLBI · EMORY UNIVERSITY · fiscal years 2004 to 2008 · $557,530 awarded in 2008Grant number is on one of their registry trials
- EFFECT OF VALSARTAN ON CAROTID ATHEROSCLEROSIS, ENDOTHELIAL, OXIDATIVE STRESS,M01RR000039 · NCRR · EMORY UNIVERSITY · fiscal years 2004 to 2007 · $35,862 awarded in 2007Same name and institution; not confirmed by an ID
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Morehouse-Emory Partnership to Reduce CV DisparitiesU01HL079214 · NHLBI · MOREHOUSE SCHOOL OF MEDICINE · PI Gary H Gibbons · fiscal years 2004 to 2008Named on NCT00101517
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 10:16 UTC. The ranking covers the 200 most relevant of 69 PubMed records, and a shared surname and initials can bring in a namesake. All 69 on PubMed
- 584 citationsRCR 17.9
- Imipramine in patients with chest pain despite normal coronary angiograms.N Engl J Med · 1994359 citationsRCR 11.2
- 310 citationsRCR 9.1
- Circadian variation of total ischaemic burden and its alteration with anti-anginal agents.Lancet · 1988294 citationsRCR 13.8
- Contribution of nitric oxide to metabolic coronary vasodilation in the human heart.Circulation · 1995266 citationsRCR 7.9
- Aspirin improves endothelial dysfunction in atherosclerosis.Circulation · 1998225 citationsRCR 5.7
- The effect of sildenafil on human vascular function, platelet activation, and myocardial ischemia.J Am Coll Cardiol · 2002222 citationsRCR 5.8
- Mental Stress-Induced-Myocardial Ischemia in Young Patients With Recent Myocardial Infarction: Sex Differences and Mechanisms.Circulation · 2018203 citationsRCR 9.5
- Acute and chronic angiotensin-1 receptor antagonism reverses endothelial dysfunction in atherosclerosis.Circulation · 2000159 citationsRCR 4.1
- Effect of antioxidant vitamins on low density lipoprotein oxidation and impaired endothelium-dependent vasodilation in patients with hypercholesterolemia.J Am Coll Cardiol · 1994151 citationsRCR 4.6